Cytokines in acute chikungunya

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Venugopalan, Anuradha ^a   Ghorpade, Ravi P ^a   Chopra, Arvind ^a  

^a Center for Rheumatic Diseases   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHIKUNGUNYA ALPHAVIRUS ANTIBODY; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ACUTE DISEASE; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD EXAMINATION; CHIKUNGUNYA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FATIGUE; FEMALE; FEVER; HEALTH SURVEY; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOFLUORESCENCE TEST; IMMUNOREGULATION; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MYALGIA; RURAL POPULATION; SYMPTOM; UPREGULATION; ACUTE PHASE RESPONSE; AGE; ANTIBODY PRODUCTION; BLOOD; CASE CONTROL STUDY; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; QUESTIONNAIRE; REGRESSION ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

ACUTE DISEASE; ACUTE-PHASE REACTION; ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CASE-CONTROL STUDIES; CHIKUNGUNYA FEVER; COHORT STUDIES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908546264     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111305     Document Type: Article

References (36)

1. Chopra A, Anuradha V, Ghorpade R, Saluja M (2012) Acute Chikungunya (CHIKV) and persistent musculoskeletal pain following the 2006 Indian epidemic: A two year prospective rural community study. Epidemiol Infect 140(5): 842-50.
2. Chopra A, Anuradha V (2011) Persistent rheumatic musculoskeletal pain and disorders at one year post-chikungunya epidemic in south Maharashtra - a rural community base observational study with special focus on naïve persistent rheumatic musculoskeletal cases and selected cytokine expression. Indian J Rheumatol 6(1): 5-11.
3. Yergolkar PN, Tandale BV, Arankalle VA, Sathe PS, Sudeep AB, et al. (2006) Chikungunya outbreaks caused by African genotype, India. Emerg Infect Dis 12(10): 1580-1583.
4. Hapuarachchi HAC, Bandara KBAT, Hapugoda MD, Williams S, Abeyewickreme W (2008) Laboratory confirmation of dengue and chikungunya coinfection. Ceylon Med J 53: 104.
5. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M (2007) Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7: 319-27.
6. Noridah O, Paranthaman V, Naya SK, Masliza M, Ranjit K, et al. (2007) Outbreak of Chikungunya due to virus of Central/East African genotype in Malaysia. Med J Malaysia 62: 323-328.
7. Leo YS, Chow ALP, Tan LK, Lye DC, Lin L, et al. (2009) Chikungunya outbreak, Singapore, 2008. Emerg Infect Dis 15: 836-837.
8. Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, et al. (2008) Chikungunya virus aches and pains: An emerging challenge. Arthritis Rheum 58(9): 2921-2922.
9. Brighton SW, Porzesky OW, De La Harpe AL (1983) Chikungunya virus infection. A retrospective study of 107 cases. South African Med J 63: 313-315.
10. CTK Biotech website. Available: http://ctkbiotech.com/ctk-product/ chikungunya-igm-combo-rapid-test/. Accessed 2014 Oct 04.
11. Chopra A (2009) Community rheumatology in India-A COPCORD driven perspective. Indian J Rheumatol 4(3): 119-126.
12. Morceau F, Dicato M, Diederich M (2009) Pro-inflammatory cytokine-mediated anemia: Regarding molecular mechanisms of erythropoiesis. Mediators Inflamm 2009: 405016. doi:10.1155/2009/405016.
13. Kalantri SP, Joshi R, Riley LW (2006) Chikungunya epidemic: An Indian perspective. Natl Med J India 19: 315-322.
14. Kam YW, Ong EKS, Renia L, Tong JC, Ng LFP (2009) Immuno-biology of Chikungunya and implications for disease intervention. Microbes and Infection 11: 1186-1196.
15. st edition. London: Saunders. 737-738.
16. Lakshmi V, Neeraja M, Subbalaxmi MVS, Patida MM, Dash PK, et al. (2008) Clinical features and molecular diagnosis of Chikungunya fever from South India. Clin Infect Dis 46: 1436-1442.
17. Lum FM, Teo TH, Lee WW, Kam YW, Rénia L, et al. (2013) An essential role of antibodies in the control of Chikungunya virus infection. J Immunol 190: 6295-6302.
18. Hiscott J (2007) Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 282: 15325-15329.
19. Gifford GE, Heller E (1963) Effect of actinomycin D on interferon production by 'active' and 'inactive' chikungunya virus in chick cells. Nature 200: 50-51.
20. Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, et al. (2008) Mouse model for chikungunya: young age and inefficient type-1 interferon signaling are risk factors for severe disease. PLoS Pathog 4(2)e 29: 0001-0012.
21. Ziegler SA, Lu L, Travassos RA, Xiao SY, Tesh RB (2008) An animal model for studying pathogenesis of Chikungunya virus infection. Am J Trop Med 79(1): 133-139.
22. Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, et al. (2010) Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med 207(2): 429-442.
23. Barr TA, Brown S, Mastroeni P, Gray D (2009) B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c. J Immunol 183: 1005-1012.
24. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, et al. (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120: 894-906.
25. Ng LFP, Chow A, Sun YJ, Kwek DJC, Lim PL, et al. (2009) IL-1b, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS ONE 4(1): e4261. doi:10.1371/journal.pone.0004261.
26. Suhrbier A, Mahanlingam S (2009) The immunobiology of viral arthritides. Pharmacol Ther 124: 301-308.
27. Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, et al. (2007) Human muscle satellite cells as targets of Chikungunya virus infection. PLoS ONE 2(6): e527.doi:10.1371/journal.pone.0000527.
28. Aliprantis AO, Wang J, Fathman JW, Lemaire R, Dorfman DM, et al. (2007) Transcription factor T-beta regulates skin sclerosis through its function in innate immunity and vial IL-13. Proc Natl Acad Sci USA 104(8): 2827-2830.
29. Chow A, Her Z, Ong EKS, Chen J, Dimatatac F, et al. (2011) Persistent arthralgia induce by Chikungunya virus infection is associated with Interleukin -6 and granulocyte macrophage colony stimulating factor. J Infect Dis 203: 149-157.
30. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, et al. (2011) Inflammatory cytokine expression is associated with Chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 5(8): e1279, doi:10.1371/ journl.pntd.0001279.
31. Chaaithanya IK, Muruganandam N, Sundaram SG, Kawalekar O, Sugunan AP, et al. (2011) Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol 24(4): 265-271.
32. Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, et al. (2012) Chikungunya disease: Infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 6(3): e1446. doi:10.1371/journal.pntd.0001446.
33. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, et al. (2011) The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis 204 (1): 115-123.
34. El-Gabalawy HS, Robinson DB, Smolik I, Hart D, Elias B, et al. (2012) Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. Arthritis Rheum 64(6): 1720-1729.
35. Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, et al. (2010) Upregulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 62(2): 383-391.
36. Chopra A, Saluja M, Anuradha V (2013) Chloroquine effectiveness and inflammatory cytokine response in early persistent post Chikungunya musculoskeletal pain and arthritis. Arthritis Rheum 66(2): 319-326.